IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $5,475,241 | +19.3% | 478,605 | +0.4% | 0.04% | +10.0% |
| Q3 2023 | $4,589,263 | -10.5% | 476,559 | -1.1% | 0.04% | -7.0% |
| Q2 2023 | $5,128,352 | -4.1% | 481,988 | -5.1% | 0.04% | +95.5% |
| Q1 2023 | $5,345,234 | +150.2% | 508,102 | +146.4% | 0.02% | +10.0% |
| Q3 2022 | $2,136,000 | -14.2% | 206,221 | -4.5% | 0.02% | -9.1% |
| Q2 2022 | $2,489,000 | -13.1% | 215,861 | -5.2% | 0.02% | +4.8% |
| Q1 2022 | $2,865,000 | +14.4% | 227,710 | +6.0% | 0.02% | +16.7% |
| Q4 2021 | $2,504,000 | -10.7% | 214,754 | 0.0% | 0.02% | -14.3% |
| Q3 2021 | $2,805,000 | – | 214,754 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |